MedPath

Efficacy Study of a Facemask Device to Treat Hypotension

Phase 2
Completed
Conditions
Hypotension
Interventions
Device: sham ITD
Device: Impedance Threshold Device
Registration Number
NCT00256724
Lead Sponsor
Advanced Circulatory Systems
Brief Summary

The purpose of this study is to determine if the impedance threshold device (ITD) attached to a facemask can increase blood pressure in patients who present to the emergency department with hypotension secondary to hypovolemia. The cause of hypovolemia could be blood loss, sepsis, or dehydration.

Detailed Description

The study is designed to test the hypothesis that use of the ITD will result in a rapid rise in blood pressure secondary to an increase in cardiac output. Either an active or sham ITD will be applied to hypotensive patients when initially presented to the emergency department with a systolic blood pressure of \<95mmHg. The main endpoint of this study will be the rise in blood pressure over the first 10 minutes of use. Based upon pre-clinical studies as well as clinical studies performed to date, we hypothesize that use of the active ITD will result in a more rapid and higher blood pressure than the sham ITD. Multiple additional clinical parameters will also be compared between the two groups of patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
47
Inclusion Criteria
  • Conscious patient
  • Systolic blood pressure < 95 mmHg
  • Hypotension caused by blood loss, sepsis, or dehydration
Exclusion Criteria
  • Hypotension secondary to heart failure
  • Complaints of chest pain
  • History of heart failure
  • Complaints of shortness of breath

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham ITDsham ITDsham Impedance Threshold Device
active ITDImpedance Threshold Deviceactive impedance threshold device
Primary Outcome Measures
NameTimeMethod
Rise in Systolic Blood Pressure Over the First 10 Minutes of Use Compared to Baselineevery 2 minutes during 10 minutes of device use
Secondary Outcome Measures
NameTimeMethod
Quantity of Fluid Administrationduring 10 minutes of device use

Trial Locations

Locations (1)

Hennepin County Medical Center

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath